{"id":"W4225303623","doi":"10.1007/s40257-022-00685-0","title":"Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Glenmark Pharmaceuticals; LEO Pharma; Galderma; Incyte; Dermira; Regeneron Pharmaceuticals; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Pharmacotherapy; Off-label use; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002759507,0.0003854235,0.0008190196,0.0001805428,0.0003497917,0.0004983724,0.0002129089,0.0005204538,0.001419079],"category_scores_gemma":[0.001566806,0.0002063538,0.0008735537,0.0001858568,0.0002830288,0.0005792237,0.0002122953,0.001007381,0.0002435447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002990182,"about_ca_system_score_gemma":0.0005012359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004619199,"about_ca_topic_score_gemma":0.001691249,"domain_scores_codex":[0.9992146,0.0004314423,0.00006601772,0.00008916877,0.0001024327,0.00009629258],"domain_scores_gemma":[0.9990504,0.0002548528,0.0002524017,0.00009398948,0.0001167586,0.0002316212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5900599,0.03238311,0.06790812,0.00131602,0.002860239,0.0005531516,0.0009525262,0.0008772197,0.06237614,0.0002140869,0.003182214,0.2373171],"study_design_scores_gemma":[0.1115189,0.6282118,0.2403996,0.00009453824,0.001999508,0.0008123452,0.0002542055,0.001694156,0.008191554,0.0001694661,0.006595771,0.00005822166],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973003,0.001331288,0.0001628735,0.000104981,0.00002422196,0.0002152792,0.0002667359,0.00001595718,0.000578245],"genre_scores_gemma":[0.9979157,0.0004791571,0.0003492292,0.0001670037,0.00005817604,0.0001730041,0.0003878624,0.00000358795,0.0004663664],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002759507,"threshold_uncertainty_score":0.01459384,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.036607971002882,"score_gpt":0.388442262458741,"score_spread":0.351834291455859,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}